Publication date: 1 February 2027 Source: Neuropharmacology, Volume 303 Author(s): Sara M. Herz, Abrar M. Khan, Isis Betancourt-Toscano, Caleb G. Tiron, Viviane N. Ton, Dana E. Selley, M. Imad Damaj
Inhibition of the sphingosine-1-phosphate receptor 1 (S1PR1) as a therapeutic target for aromatase inhibitor-induced musculoskeletal symptoms in mice. // Emerging Trends in Drugs, Addictions, and Health. – URL: https://www.sciencedirect.com/science/article/pii/S0028390826004144?dgcid=rss_sd_all
Inhibition of the sphingosine-1-phosphate receptor 1 (S1PR1) as a therapeutic target for aromatase inhibitor-induced musculoskeletal symptoms in mice. Emerging Trends in Drugs, Addictions, and Health. https://www.sciencedirect.com/science/article/pii/S0028390826004144?dgcid=rss_sd_all
“Inhibition of the sphingosine-1-phosphate receptor 1 (S1PR1) as a therapeutic target for aromatase inhibitor-induced musculoskeletal symptoms in mice.” Emerging Trends in Drugs, Addictions, and Health.
@article{article13972,
title = {Inhibition of the sphingosine-1-phosphate receptor 1 (S1PR1) as a therapeutic target for aromatase inhibitor-induced musculoskeletal symptoms in mice},
journal = {Emerging Trends in Drugs, Addictions, and Health},
url = {https://www.sciencedirect.com/science/article/pii/S0028390826004144?dgcid=rss_sd_all}
}